Publication | Open Access

The effectiveness and value of lecanemab for early Alzheimer disease: A summary from the Institute for Clinical and Economic Review’s California Technology Assessment Forum

Early Alzheimer DiseaseNeurodegenerative DiseasesNeurobiology Of DiseaseAlzheimer's DiseaseTreatment EvaluationVascular DementiaEconomic Review ’NeurologyAging-associated DiseaseNeurodegenerationMedicineTreatmentGeriatric Neurology